Canadian Consensus Recommendations on the Management of MET-Altered NSCLC

In Canada, the therapeutic management of patients with advanced non-small cell lung cancer (NSCLC) with rare actionable mutations differs between provinces, territories, and individual centres based on access to molecular testing and funded treatments. These variations, together with the emergence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Parneet K., Banerji, Shantanu O., Blais, Normand, Chu, Quincy S.-C., Desmeules, Patrice, Juergens, Rosalyn A., Leighl, Natasha B., Sheffield, Brandon S., Wheatley-Price, Paul F., Melosky, Barbara L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628757/
https://www.ncbi.nlm.nih.gov/pubmed/34898564
http://dx.doi.org/10.3390/curroncol28060386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628757/
https://www.ncbi.nlm.nih.gov/pubmed/34898564
http://dx.doi.org/10.3390/curroncol28060386

Ejemplares similares